- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01303653
Endoscopic Treatment of Intestinal Fistulas and Perforations
Study Overview
Status
Intervention / Treatment
Detailed Description
Novel endoscopic devices have the potential to overcome the need for invasive surgery for the treatment of gastrointestinal fistulas or perforations.
Instead of a large abdominal incision or multiple incisions with the related postoperative morbidity endoscopic techniques will be used used which require no postoperative limitation of activities. Using novel tissue closure devices, such as a Tissue Apposition System or an endoscopic suturing system, we will evaluate the potential benefit, risks and impact on the patient's quality of life of this modified surgical technique in patients having either chronic gastrointestinal fistulas or acute perforations.
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97210
- Recruiting
- Good Samaritan Hospital, Legacy Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Gastrointestinal fistula and perforation
- Ability to undergo general anesthesia
- Ability to give informed consent
Exclusion Criteria:
- Contraindicated for esophagogastroduodenoscopy (EGD)
- Contraindicated for colonoscopy
- BMI ≥ 40
- Presence of esophageal stricture
- Altered gastric anatomy
- Intraabdominal abscess or severe inflammation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with adverse events as a measure of safety and tolerability
Time Frame: 6 months
|
elective endoscopy to evaluate tissue closure
|
6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LEG 1280
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Fistula
-
Jinling Hospital, ChinaUnknownLow-output External Gastrointestinal FistulaChina
-
Jinling Hospital, ChinaUnknownLow-output External Gastrointestinal FistulaChina
-
University Hospital, AkershusUniversity Hospital, Linkoeping; Region Örebro County; Uppsala University HospitalCompletedPerianal FistulaNorway
-
Zagazig UniversityCompletedTranssphincteric Anal FistulaEgypt
-
London North West Healthcare NHS TrustCompletedFistula in Ano | Ano FistulaUnited Kingdom
-
Rush University Medical CenterTerminatedRectal Fistula | Anal Fistula | Fistula in Ano | Transsphincteric FistulaUnited States
-
Tehran University of Medical SciencesRecruitingFistula PerianalIran, Islamic Republic of
-
Sykehuset Innlandet HFWithdrawn
-
The University of Texas Health Science Center,...CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCESRecruiting
-
RedDress Ltd.RecruitingAnal FistulaUnited States, Israel
Clinical Trials on endoscopic closure of gastrointestinal fistulas and perforations
-
Chinese University of Hong KongRecruiting
-
Institute for Clinical and Experimental MedicineCompleted
-
University Hospital TuebingenCompletedAnastomotic Leak EsophagusGermany
-
Mayo ClinicMauna Kea TechnologiesCompleted
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Pichamol Jirapinyo, MD, MPHNot yet recruitingLiver Diseases | Metabolic Diseases | Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Insulin Resistance | Weight Loss | Liver Fat | NAFLD | Insulin Sensitivity/Resistance | Insulin Sensitivity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non Alcoholic Fatty... and other conditionsUnited States
-
Karolinska InstitutetWithdrawnPancreatic Neoplasms | Biliary Tract Neoplasms | Duodenal NeoplasmsSweden
-
Al-Azhar UniversityHelwan University; National Liver Institute, EgyptCompletedCOVID-19 | Cholangiocarcinoma | SARS-CoV-2 | Pancreas Cancer | Obstructive Jaundice | Cholangitis, Secondary BiliarySingapore, Germany, United States, Egypt, Peru
-
All India Institute of Medical Sciences, New DelhiIndian Council of Medical ResearchCompleted
-
Societa Italiana di Chirurgia ColoRettaleTerminated